The page is the record's research on the issuer — no analyst, no rating, no view. # Evommune, Inc. (NYSE: EVMN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Evommune, Inc., listed on the NYSE under ticker EVMN, with ISIN US30054Y1073. The LEI is not on the record. The security type is Corporate, the segment is not on the record, and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Delaware. The status is listed, not halted. ## The disclosure read The record holds 92 filings in the window 2025-11-08 to 2026-11-08, across 38 filing days. The filings comprise 42 directors' dealings, 20 regulatory filings, 11 corporate news, 8 prospectus, 8 results and 3 AGM/EGM filings. The median gap between filing days is 6 days. The latest filing is dated 2026-11-05 and is of type corporate news, 3 days before the record date. The NYSE median cadence gap is 6.0 days, with a median of 64.0 filings and a median latency of 4.0 days across 3,256 issuers. The sector median cadence gap is 6.0 days, with a median of 63.0 filings and a median latency of 4.0 days across 526 issuers. ## Auditor The auditor is not on the record, as the latest annual report cover carries no auditor name tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2025-11-04 and 2025-11-05. It holds no delisting, no name change, and no segment move; the segment move is not on the record. The domicile change is not on the record. The issuer is listed and not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage The issuer's investor-relations page names 13 research houses: Cantor, Clear Street, Evercore ISI, HC Wainwright, Leerink Partners, Morgan Stanley, Needham, Oppenheimer, Raymond James, RBC Capital Markets, Stifel, UBS and William Blair. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002044725.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/EVMN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://ir.evommune.com/stock-data/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NYSE/EVMN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/EVMN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp